Risperdal is used to treat schizophrenia and bipolar mania.
Increased occurrences of diabetes, hyperglycemia, and weight gain have been associated with the use of Risperdal.
Drug companies have pushed atypical antipsychotics like Risperdal too quickly, to the wrong patients. The results? Unnecessarily exposing patients to potentially dangerous, long-term side effects such as diabetes and weight gain.
Children and the elderly are also adversely affected by drugs like Risperdal.
As reported by the FDA in December of 2003:
FDA and Janssen revised the WARNINGS section of labeling, describing the increased risk of hyperglycemia and diabetes in patients taking Risperdal. MedWatch is posting a revised version of a letter originally distributed to health care professionals November 2003. FDA asked all manufacturers of atypical antipsychotic medications, including Janssen, to add this Warning statement to labeling.
If you are suffering from any of the following conditions after taking this drug, you may need to seek help/advise.
- Severe weight gain
- Diabetic coma
- Heart attack
- Neuroleptic Malignant Syndrome
- Tardive Dyskinesia